Ofatumumab

Results: 36



#Item
1Clinical medicine / Medicine / Breakthrough therapy / Cancer / B-cell chronic lymphocytic leukemia / Obinutuzumab / Ofatumumab / Ibrutinib / Rituximab / Leukemia / Idelalisib / Phosphoinositide 3-kinase inhibitor

Interim statement from the BCSH CLL Guidelines Panel George A Follows1, Adrian Bloor2, Claire Dearden3, Steve Devereux4, Christopher P Fox5, Peter Hillmen6, Ben Kennedy7, Helen McCarthy8, Nilima Parry-Jones9, Piers EM Pa

Add to Reading List

Source URL: www.bcshguidelines.com

Language: English - Date: 2015-07-22 04:38:28
2Paragraph / Comparative Toxicogenomics Database / Ofatumumab / CD20 / Biology / Workflow / Science / Business / Typography / Writing / Workflow technology

Text mining workflow for extraction of paragraphs from full articles describing drug-gene interactions to support Onco KEM software platform for personalized treatments Fanny Perraudeau, David Morley, Mohammad Afshar, Ma

Add to Reading List

Source URL: www.winsymposium.org

Language: English - Date: 2014-10-06 16:46:25
3Vorinostat / Cutaneous T-cell lymphoma / Ofatumumab / Medicine / Lymphoma / Hematopoietic stem cell transplantation

Legend Non-Hodgkin Lymphoma (NHL) Open to AccrualPh 2b Open-label, Randomized Two Arm Study of Selinexor plus Low

Add to Reading List

Source URL: cancer.ucsf.edu

Language: English - Date: 2014-10-06 14:59:55
4Carbamates / Medicine / Lactams / Pefloxacin / B-cell chronic lymphocytic leukemia / Norfloxacin / Darunavir / Leukemia / Ofatumumab / Piperazines / Chemistry / Organic chemistry

PDF Document

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2015-01-29 12:17:03
5Genmab / Ofatumumab / Winkel /  North Holland

Q&A GENMAB 16. august 2012 Med CEO Jan Van de Winkel Transcript Live Q and A Genmab CEO Jan Van de Winkel, 16. august 2012 Akademikeren

Add to Reading List

Source URL: www.proinvestor.com

Language: English - Date: 2012-08-27 06:36:22
6Winkel / Zalutumumab / Pharmacology / Pharmaceutical industry / Medicine / Genmab / Ofatumumab / HuMax

Q&A GENMAB 8TH OF MAY 2014 WITH JAN VAN DE WINKEL Q&A GENMAB 8TH OF MAY 2014

Add to Reading List

Source URL: www.proinvestor.com

Language: English - Date: 2014-05-08 09:31:02
7Genmab / Ofatumumab

Q&A GENMAB 8. maj 2013 Med CEO Jan Van de Winkel Transcript Live Q and A Genmab CEO Jan Van de Winkel, 8. maj 2013 Akademikeren

Add to Reading List

Source URL: www.proinvestor.com

Language: English - Date: 2013-07-04 10:49:53
8Winkel /  North Holland / HuMax / Pharmacology / Pharmaceutical industry / Genmab / Ofatumumab / Winkel /  Rhineland-Palatinate

Q&A GENMAB 14TH OF AUGUST 2014 WITH JAN VAN DE WINKEL Q&A GENMAB 14TH OF AUGUST 2014

Add to Reading List

Source URL: www.proinvestor.com

Language: English - Date: 2014-08-15 10:03:52
9Winkel / Pharmacology / Pharmaceutical industry / Genmab / Ofatumumab / HuMax

Q&A GENMAB 6TH OF NOVEMBER 2014 WITH JAN VAN DE WINKEL Q&A GENMAB 6TH OF NOVEMBER 2014

Add to Reading List

Source URL: www.proinvestor.com

Language: English - Date: 2014-11-07 05:21:11
10Pharmacology / Genmab / Ofatumumab / HuMax

Q&A GENMAB 15. AUGUST 2013 MED JAN VAN DE WINKEL Q&A GENMAB 15. AUGUST 2013

Add to Reading List

Source URL: www.proinvestor.com

Language: English - Date: 2013-08-16 08:55:48
UPDATE